Bohlin, SE
Ake Bohlin, Alingsas SE
Patent application number | Description | Published |
---|---|---|
20140076624 | Cable Termination Device, A Method For Prefabricating A Cable Termination Device And A Method For Achieving A Cable Termination - A cable termination device of the dry type, for terminating a high voltage cable, including an insulator housing with a first end and a second end and having a hollow interior, and which second end has an opening for insertion of a high voltage cable. The cable termination device further includes a stress controller device located inside the insulator housing and adapted to be mounted on a high voltage cable, an end cap located at the first end of the insulator housing and provided with an external electrical connection means, and an electrically insulating gel filling at least part of the hollow interior of the insulator housing and surrounding at least part of the stress controller device. Further, the stress controller device is provided with a first and a second deflector arrangement for controlling an electric field. | 03-20-2014 |
Gunnar Bohlin, Gardsjo SE
Patent application number | Description | Published |
---|---|---|
20120145771 | DEVICE AND METHOD FOR AUTOMATIC MULTIPLE-BEAD WELDING - A welding device and a method for automatic multiple-bead welding, wherein a line illumination member is arranged to illuminate the joint by scanning a light beam across the joint line. A camera is arranged for the registration of line images of the joint when it is illuminated with the scanned light beam. The locations of the edges of the joint are determined by means of triangulation based on the registered line image. The welding device can include a stereo image member arranged to register photometric stereo images of the joint substantially simultaneously with the registration of the line images. The welding device is arranged to, during welding of a weld joint with a plurality of weld beads, control the welding head in dependence on both stereo images and line images. | 06-14-2012 |
Jan Bohlin, Harbo SE
Patent application number | Description | Published |
---|---|---|
20120330435 | Implants and Methods for Correcting Tissue Defects - The present invention relates to mosaic implant ( | 12-27-2012 |
20140195004 | Implants and Methods for Correcting Tissue Defects - The present invention relates to mosaic implant ( | 07-10-2014 |
20140324187 | Implants and Methods for Correcting Tissue Defects - An implant comprises a plurality of discrete biocompatible molded cement mosaic plates of maximum width w and thickness d connected by wire arms molded into and extending substantially laterally from the mosaic plates. Neighbouring mosaic plates are separated by a gap of width t, and at least some of the mosaic plates have a hexagon shape. | 10-30-2014 |
20150374497 | Mosaic Implants, Kits and Methods for Correcting Bone Defects - A mosaic implant conformable to a curved surface, comprising first and second implant sections coupled along a beam portion extending across a length of the implant, each of the implant sections having—a plurality of biocompatible mosaic plates, and—a plurality of wires which interconnect the plates with one another. The mosaic implant is configured to be deformable such that at least a portion of the mosaic implant is conformable to a curved surface, with the beam portion providing structural support which resists inward deformation of the curved portion of the implant. A kit for forming a mosaic implant is also provided, along with a method for correcting a bone defect in a patient. | 12-31-2015 |
Jonas Bohlin, Linkoping SE
Patent application number | Description | Published |
---|---|---|
20150292074 | A POROUS COATING APPLIED ONTO AN AERIAL ARTICLE - An aerial article including a composite skin, a leading edge facing an airflow during use of the aerial article, an erosion resistant coating including a metallic material, and an aerodynamic surface. The coating at least partly covers the composite skin of the aerial article. The coating has a porosity sufficiently high to provide an open area, diffusion passage way, so as to permit moisture transportation from the composite skin to the aerodynamic surface of the coating. A method of applying an erosion resistant coating including a metallic material to a composite skin of an aerial article. An erosion resistant coating material is provided onto the composite skin over a selected area of the article. The coating is porous. The outer surface of the coating is polished to achieve a smooth aerodynamic surface. | 10-15-2015 |
Kjell Bohlin, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20140346976 | METHOD FOR MANUFACTURING NANOSTRUCTURES AND CATHODE FOR FIELD EMISSION LIGHTING ARRANGEMENT - The present invention relates to a method for manufacturing a plurality of nanostructures comprising the steps of providing a plurality of protruding base structures ( | 11-27-2014 |
Lars Bohlin, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20090099068 | ON-GROWTH INHIBITING COMPOUNDS - An on-growth inhibiting agent, for the inhibition and/or prevention of on-growth of biological organisms on objects or living beings, includes at least one cyclotide, and a suitable carrier medium. A plant extract containing a mixture of cyclotides is also usable. | 04-16-2009 |
20090124634 | Novel dipodazine compounds and applications - The invention relates to a novel class of dipodazine derivatives, suitable for use as surface on-growth inhibiting agents. | 05-14-2009 |
Martin Bohlin, Johanneshov SE
Patent application number | Description | Published |
---|---|---|
20160039777 | CRYSTAL MODIFICATIONS OF ELOBIXIBAT - The present invention relates to crystal modifications of N-{(2R)-2-[({[3,3-dibutyl-7-(methyl-thio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl]oxy}acetyl)amino]-2-phenylethanolyl}glycine (elobixibat), more specifically crystal modifications I, IV, MeOH-1, EtOH-1, 1-PrOH-1 and 2-PrOH-1. The invention also relates to a process for the preparation of these crystal modifications and to a pharmaceutical composition comprising crystal modification IV. | 02-11-2016 |
Martin Bohlin, Sodertalje SE
Patent application number | Description | Published |
---|---|---|
20080269297 | Process for the Preparation of Esomeprazole Non-Salt Form - The present invention relates to a new process for the preparation of new crystal modifications of esomeprazole non-salt form. Further, the present invention also relates to the use of said new crystal modifications for the treatment of gastrointestinal disorders, pharmaceutical compositions containing them as well as the crystal modifications, as such. | 10-30-2008 |
20100022610 | New Crystalline Forms - A salt of the compound N-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}ethanesulfonamide, which is an ethanesulphonic acid salt, a sulphuric acid salt, an ethane disulphonic acid salt, a hydrochloric acid salt, a hydrobromic acid salt, a phosphoric acid salt, an acetic acid salt, a fumaric acid salt, a maleic acid salt, a tartaric acid salt, a citric acid salt, a methanesulphonic acid salt, or a p-toluenesulphonic acid salt of said compound. | 01-28-2010 |
20100137304 | NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839 - The invention concerns certain crystalline solvates and hydrates of the compound of the Formula I | 06-03-2010 |
Martin Bohlin, Molndal SE
Patent application number | Description | Published |
---|---|---|
20080269176 | New Salts - There is provided pharmaceutically-acceptable acid addition salts of compounds of formula (I), | 10-30-2008 |
Martin Bohlin, Södertälje SE
Patent application number | Description | Published |
---|---|---|
20100022610 | New Crystalline Forms - A salt of the compound N-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}ethanesulfonamide, which is an ethanesulphonic acid salt, a sulphuric acid salt, an ethane disulphonic acid salt, a hydrochloric acid salt, a hydrobromic acid salt, a phosphoric acid salt, an acetic acid salt, a fumaric acid salt, a maleic acid salt, a tartaric acid salt, a citric acid salt, a methanesulphonic acid salt, or a p-toluenesulphonic acid salt of said compound. | 01-28-2010 |
Martin Hans Bohlin, Macclesfield Cheshire SE
Patent application number | Description | Published |
---|---|---|
20150038524 | CRYSTALLINE NALOXOL-PEG CONJUGATE - Naloxol-polyethylene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided. | 02-05-2015 |
Martin Hans Bohlin, Sodertalje SE
Patent application number | Description | Published |
---|---|---|
20100249196 | Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine - Phosphoric acid, edisylic acid (1,2-ethanedisulfonic acid), citric acid, orotic acid (uracil-6-carboxylic acid), R-mandelic acid, sulfuric acid, 1,5-naphthalenedisulfonic acid, D-aspartic acid, and lysine monohydrochloride salts of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine, and methods for their preparation, pharmaceutical compositions comprising said salts, and use, are disclosed. The salts can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders. | 09-30-2010 |
20110009647 | Process 054 - The present invention is directed to a process for the preparation of a diastereomerically pure dibenzoyl-L-tartrate salt of a compound of formula (III) | 01-13-2011 |
20120101274 | Process For Preparing [1S-[1-alpha, 2-alpha, 3-beta (1S*,2R*) 5-beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H- -1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol And To Its Intermediates - The present invention is directed to a process for preparing [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and to intermediates useful in the process. | 04-26-2012 |
20150283257 | CRYSTALLINE NALOXOL-PEG CONJUGATE - Naloxol-polyethylene glycol conjugates of the formula: | 10-08-2015 |